βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerDaniel C. Christoph(Evangelisches Krankenhaus Königin Elisabeth Herzberge), Jeremias Wohlschlaeger(DIAKO)British Journal of CancerJuly 26, 201210.1038/bjc.2012.324Cited by 35SaveCiteExport RISWatch citationsRelated PapersCONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy|Journal of Clinical Oncology|2024|57